The expanding use of lipidomics will most likely establish which DAG species are responsible for generating the PKC isoform/s that is vitally linked with IR in in vivo human clinical settings, and pave the way for pharmacological interventions that will arrest the progression of DAG-induced skeletal muscle IR to T2DM. This evidence concerns the gene PRRT2 and type 2 diabetes mellitus.